Hideki Uryu

Profile Information

Affiliation: Assistant Professor, Division of Clinical Oncology and Hematology, The Jikei University School of Medicine

Degree: Doctor of Medical Science(Jan, 2022, The Jikei University School of Medicine)

当院における慢性特発性血小板減少性紫斑病に対するリツキシマブ療法の治療経験(Efficacy of rituximab in chronic immune thrombocytopenia: a retrospective survey at Kashiwa Hospital)

西脇嘉一, 香取美津治, 瓜生英樹, 平野慧, 細羽梨花, 郡司匡弘, 鈴木一史, 増岡秀一, 矢野真吾

臨床血液, 59(9) 1580-1580, Sep, 2018
Clonal evolutionは急性骨髄性白血病の同種移植後の予後に影響する(Clonal evolution predicts the post-transplantation outcome in acute myeloid leukemia)

横山洋紀, 齋藤健, 島田貴, 南次郎, 勝部敦史, 神山祐太郎, 鈴木一史, 福島僚子, 石井敬人, 石井彰子 …

臨床血液, 59(9) 1616-1616, Sep, 2018
レナリドミドを含む救援化学療法中にみられる好酸球増多は次治療までの期間延長の予後因子

鈴木一史, 西脇嘉一, 香取美津治, 郡司匡弘, 瓜生英樹, 増岡秀一, 矢野真吾

International Journal of Myeloma, 8(2) 139-139, May, 2018

Accompanying with additional complex karyotype is a poor prognostic factor in patients with multiple myeloma with high-risk cytogenetics in the era of novel agents

H. Uryu, N. Nishimura, Y. Mishima, Y. Ishihara, Y. Shirouchi, M. Tanba, D. Maruyama

18th International Myeloma Workshop, Sep, 2021
Transformed follicular lymphoma in relation with rituximab maintenance and chromosome 8 aberrations

Oct, 2020
Cell-free DNA genotyping analysis in diffuse large B-cell lymphoma; the correlation between TP53 gene mutation and cereblon gene mutation

Uryu, H, Mishima, Y, Mishima, Y, Yokoyama, M, Nishimura, N, Kusano, Y, Okabe, T, Inoue, N, Fukuta, T, Shirouchi, Y, Hatake, K, Teuri, Y

61st American Society of Hematology Annual Meeting, Dec, 2019
Outcomes for transformed diffuse large B cell lymphoma in comparison with de-novo DLBCL

Oct, 2019
Efficacy of Rituximab Maintenance for Diffuse large B cell lymphoma with transformation

Hideki Uryu, Yuko Mishima, Masahiro Yokoyama, Noriko Nishimura, Yoshiharu Kusano, Norihito Inoue, Anna Nishihara, Takanori Fukuta, Yuko Shirouchi, Naoko Tsuyama, Kengo Takeuchi, Yasuhito Terui

60th American Society of Hematology Annual Meeting, Dec, 2018